G. Haour

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Fabrice Carrat, Hélène Fontaine, Céline Dorival et al. · The Lancet · 2019 · 612 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +12

The negative impact of <scp>HBV</scp>/<scp>HCV</scp> coinfection on cirrhosis and its consequences

Stanislas Pol, G. Haour, Hélène Fontaine et al. · Alimentary Pharmacology & Therapeutics · 2017 · 89 citations

Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry

Karine Chevreul, Matthias Brunn, Benjamin Cadier et al. · Archives of cardiovascular diseases · 2013 · 68 citations

Cardiothoracic Surgery, Health Care Cost, Surgery +4

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial

David Rey, Lionel Piroth, Marie-Josée Wendling et al. · The Lancet Infectious Diseases · 2015 · 58 citations

Vaccination, Vaccine Safety, Viral Hepatitis +9

Evolution of Direct Costs in the First Years of Rheumatoid Arthritis: Impact of Early versus Late Biologic Initiation - An Economic Analysis Based on the ESPOIR Cohort

Karine Chevreul, G. Haour, Sandy Lucier et al. · PLoS ONE · 2014 · 28 citations · Full text